JAMA Neurology @JAMANeuro · 24 Aug 2026
Performance of the FDA-cleared Lumipulse plasma #biomarker for amyloid pathology detection in #AlzheimerDisease varied by site and reagent lots, highlighting need for local assay verification and ongoing quality control. https://t.co/7wNTRhICR1
2 295Views
8Likes
2Reposts
2Replies
0Quotes
9Bookmarks
Is that a lot?
0.88×vs this author's median2 597 views is typical
0Percentile for this authorof 5 recent posts
0.84×vs 10K–100K median2 743 views is typical
3.40%Reachviews ÷ followers
0.52%Engagement rateof viewers reacted